This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Two-way Interaction Between Alisporivir and EDP239
Clinical trial

Two-way Interaction Between Alisporivir and EDP239

Read time: 1 mins
Last updated:20th Jun 2014

The purpose of Part 1 is to inform dose selection for use of alisporivir and EDP239 in combination and obtain initial safety data for co-administration of alisporivir and EDP239 to support future treatment studies in patients. The purpose of Part 2 is to inform the drug-drug interaction potential of EDP239 more broadly and possibly facilitate the interpretation of lower than expected alisporivir concentrations in Part 1, if observed.

Category Value
Study start date 2014-06-20

View full details